59
likes
0
comments
daily view 0
monthly view 0
Live Analytics
Comments 0
Richard Yang, Sonablate | theCUBE + NYSE Wired: MedTech Unpluggeed Analytics Table
Income Estimates for Richard Yang, Sonablate | theCUBE + NYSE Wired: MedTech Unpluggeed
Based on this YouTube video's total view count of 9.83K views and industry-standard rates, the estimated total earning is $7 - $20 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.
About Richard Yang, Sonablate | theCUBE + NYSE Wired: MedTech Unpluggeed
Explore Richard Yang, Sonablate | theCUBE + NYSE Wired: MedTech Unpluggeed with 9,829 views, 59 likes, and 0 comments. Experience the impact of this video content that has captured audience attention.
In this interview from theCUBE + NYSE Wired: MedTech Unplugged, Richard Yang, chief executive officer of Sonablate, joins theCUBE + NYSE Wired's Gemma Allen to discuss how focused ultrasound is turning sound waves into a precision surgical tool. Yang explains how high-intensity focused ultrasound (HIFU) treats prostate cancer and BPH without incisions, targeting only the tissue that matters while preserving sexual function and continence. He details how a device delivered through the rectal wall achieves disease control comparable to prostatectomy or radiation over 10 to 15 years, backed by data from over 70,000 patients worldwide and 200 peer-reviewed publications, with patients returning home the same day. The conversation also touches on the grueling, decades-long path required to prove out a pioneering medical device, from animal studies through years of clinical follow-up before outcomes can be trusted. Yang breaks down how AI is already enhancing the platform through tools like Tissue Change Monitoring, which analyzes imaging in real time to flag under-treated tissue and guide energy adjustments, rather than replacing physician judgment. He outlines Sonablate's ambition to expand beyond urology into neuromodulation for stroke, Parkinson's and Alzheimer's, as well as soft tissue diseases, pain management and immunotherapy applications. From winning over skeptical surgeons to preparing for a planned IPO in 2027 or early 2028 alongside a $200 million pre-IPO raise, Yang lays out how Sonablate intends to scale its "treat what matters" mission across dozens of new disease areas. Find more SiliconANGLE news and analysis https://siliconangle.com/ Follow theCUBE's wall-to-wall event coverage https://siliconangle.com/events/ Learn about the latest theCUBE events https://www.thecube.net/ 00:00 - Revolutionizing Surgery: The Sonablate HIFU Journey 02:21 - Prostate Cancer Treatment and Side Effects 04:41 - From Innovation to Implementation: Navigating the MedTech Journey 06:56 - Role of AI in Medical Devices 08:57 - Advancing Sonablate: Applications and Market Strategies 15:27 - Charting the Path Ahead: Future Plans and Final Thoughts #theCUBE #MedTechUnplugged #theCUBEresearch #NYSEWired #Sonablate #MedTech #PrecisionMedicine
About YouTube Real-Time View Count
With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.
Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.
Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.
Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.
Embed Widget
Parameters:
fullscreen=true- Fullscreen countergraph=true- Live graph chartcounter=0/1/2- Select counter (0=likes, 1=views, 2=comments)
URL
Click to copy the embed URL to your clipboard

